E. Weiner et al., Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia, AM J PSYCHI, 158(4), 2001, pp. 635-637
Objective: The study examined the efficacy, tolerability, and safety of sup
portive group psychotherapy and adjunctive sustained-release bupropion for
nicotine addiction in patients with schizophrenia.
Method: Eight patients participated in a 14-week open-label trial. End expi
red breath carbon monoxide level, symptom levels, neuropsychological perfor
mance, and suppression of the P50 event-related potential were measured bef
ore and after the 14-week trial.
Results: Patients showed a decrease in carbon monoxide levels that was not
associated with any worsening in symptom, neuropsychological, or P50 suppre
ssion measures.
Conclusions: Use of sustained-release bupropion in combination with support
ive group therapy may help patients with schizophrenia decrease their cigar
ette consumption.